FIELD: biotechnology, immunology, immunobiology. SUBSTANCE: the given stabilizing composition contains protein hydrolysate, saccharose, phosphate-saline buffer, bacteriostatic, bovine serum albumin, EDTA (trilon B) and potassium chloride at the following ratio of components, weight%: bovine serum albumin 0.1-3.0; saccharose 1.0-10.0; protein hydrolysate 1.0-5.0; potassium chloride 2.0-8.0; EDTA (trilon B) 0.03-0.2; bacteriostatic 0.01-0.02; phosphate-saline buffer - the rest. Peptone and gelatin are used as protein hydrolysate and merthiolate is applied as bacteriostatic. Stabilizer provides the safety of biochemical properties of anti-IgG conjugate preparation and horse radish peroxidase during lyophilic drying, subsequent storage and rehydration at the room temperature. EFFECT: higher efficiency to obtain stable types of immunobiological preparations which keep their specific properties for a long period of time. 2 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
STABILIZING COMPOSITION FOR PREPARING REFERENCE-SERA CONTAINING IGM-ANTIBODIES | 1997 |
|
RU2136313C1 |
STRAIN OF MEASLES VIRUS NOVO/96 FOR PREPARING ANTIGEN AS COMPONENT OF TEST-SYSTEM AND IMMUNOENZYME TEST-SYSTEM FOR DIAGNOSIS OF ANTIBODIES RAISED TO MEASLES VIRUS | 2002 |
|
RU2230785C2 |
METHOD OF LYOPHILIC DRYING OF BIOLOGICAL PREPARATION | 1995 |
|
RU2111426C1 |
REAGENT FOR IMMUNOENZYME ANALYSIS AND METHOD OF IMMUNOENZYME TESTING OF SPECIFIC ANTIBODY IN OPISTHORCHIASIS CAUSED BY HEPATIC TREMATODE OPISTHORCHIS FELINEUS | 2001 |
|
RU2197736C1 |
METHOD OF LIVE ANTIMEASLES VACCINE PREPARING | 1998 |
|
RU2140288C1 |
STRAIN OF HYBRID CULTURED CELL OF ANIMAL RATTUS NORVEGICUS USED FOR PREPARING MONOCLONAL ANTIBODIES RAISED TO HUMAN HEPATITIS A VIRUS | 1997 |
|
RU2142507C1 |
LIPOSOMAL ANTIVIRAL DRUG FOR ORAL USING | 1996 |
|
RU2123328C1 |
STABILIZING COMPOSITION FOR PREPARING LYOPHILIZED PREPARATIONS ON THE BASIS OF PROTEIN A CONJUGATE AND HORSE RADISH PEROXIDASE | 1991 |
|
RU2046342C1 |
METHOD OF LIVE ANTIMEASLES VACCINE PREPARING | 1996 |
|
RU2123331C1 |
TABLET FORM OF RECOMBINANT HUMAN ERYTHROPOIETIN | 2000 |
|
RU2182830C1 |
Authors
Dates
1998-04-20—Published
1996-04-09—Filed